DRKS00034078
Not yet recruiting
未知
Intervention for the Treatment of Depression in Virtual Reality (FlowVR) - FlowVR
Asklepois Klinikum Harburg Zentrum für seelische Gesundheit Klinik für Psychiatrie, Psychotherapie und Psychosomatik0 sites66 target enrollmentApril 25, 2024
ConditionsF32F32.1F32.2F32.8F32.9F33F33.1F33.2F33.8F33.9Depressive episodeModerate depressive episodeSevere depressive episode without psychotic symptomsOther depressive episodesDepressive episode, unspecifiedRecurrent depressive disorderRecurrent depressive disorder, current episode moderateRecurrent depressive disorder, current episode severe without psychotic symptomsOther recurrent depressive disordersRecurrent depressive disorder, unspecified
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- F32
- Sponsor
- Asklepois Klinikum Harburg Zentrum für seelische Gesundheit Klinik für Psychiatrie, Psychotherapie und Psychosomatik
- Enrollment
- 66
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Meeting the criteria for Major Depression, Dysthymia, or Recurrent Depressive Disorder according to DSM\-5 verified (M.I.N.I.) with current episode, proficient in German language, providing written consent for study participation and the ability to give informed consent.
Exclusion Criteria
- •Patients with psychosis (including affective disorder with psychotic features), bipolar disorder, post\-traumatic stress disorder, acute suicidality, and substance use disorder (currently not abstinent), as well as (partial) inpatient psychotherapy during the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Psychotherapeutic INtervention for DEpression Treatment in patients with chronic Heart FailureISRCTN74936396German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany)130
Not yet recruiting
Not Applicable
Psychological Intervention to reduce depression and anxiety in cancer patients undergoing chemotherapyCancernausea in cancer patientsMental Health - AnxietyCancer - Other cancer typesMental Health - DepressionACTRN12608000493347Victorian Cancer Agency45
Completed
Not Applicable
The investigation of treatment for major depression compared monotherapy of mirtazapine, sertraline or duloxetine with combination therapy of mirtazapine and sertraline, or mirtazapine and duloxetineMajor depressionJPRN-UMIN000004567Kenichi Osada500
Completed
Not Applicable
Treatment of Depressive Symptoms using Virtual Reality (FlowVR) in Patients with DepressioF32F33F34Depressive episodeRecurrent depressive disorderPersistent mood [affective] disordersDRKS00029757niversitätsklinikum Hamburg-EppendorfKlinik für Psychiatrie und PsychotherapieStation für Angst- und Zwangsstörungen56
Not yet recruiting
Not Applicable
ightMood Intervention to reduce depression symptoms in obese adults: A randomized-controlled online intervention studyObese adults with depressive symptomsDRKS00029219VR-Universitätsklinik Essen128